Keyphrases
P-glycoprotein Activity
100%
Blood-brain Barrier
100%
Positron Emission Tomography
100%
In Vivo Measurement
100%
Alzheimer's Disease
50%
Healthy Volunteers
50%
P-glycoprotein (P-gp)
50%
Positron Emission Tomography Tracers
50%
Parkinson's Disease
25%
Healthy Individuals
25%
Model Selection
25%
Appropriate Model
25%
Alzheimer's Disease Patient
25%
Neurodegenerative Diseases
25%
Multidrug Resistance Protein 1 (MDR1)
25%
Unwanted Side Effects
25%
Transporter Proteins
25%
Drug Resistance
25%
Brain Uptake
25%
Human Body
25%
Tracer Uptake
25%
Proof of Concept Study
25%
Pharmacokinetic Study
25%
Radioactively Labeled
25%
Imaging Modalities
25%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
25%
Methodological Research
25%
Neuroscience
In Vivo
100%
Positron Emission Tomography
100%
Blood Brain Barrier
100%
Fluorine-18
100%
ABC Transporter Subfamily B
100%
Alzheimer's Disease
50%
Multidrug Resistance Protein 1
33%
Neurodegenerative Disorder
16%
Parkinson's Disease
16%
Carrier Protein
16%
Drug Resistance
16%
Pharmacokinetics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorine 18
100%
P-Glycoprotein
100%
Blood-Brain Barrier
100%
Alzheimer's Disease
50%
Normal Human
50%
Tracer
50%
Multidrug Resistance Protein 1
33%
Disease
16%
Clinical Study
16%
Side Effect
16%
Drug Resistance
16%
Preclinical Study
16%
Parkinson's Disease
16%
Drug
16%
Carrier Protein
16%
Pharmacokinetics
16%
Immunology and Microbiology
Positron Emission Tomography
100%
P-Glycoprotein
100%
Blood Brain Barrier
100%
Normal Human
50%
Multidrug Resistance Protein 1
33%
Pharmacokinetics
16%
Membrane Transport Protein
16%
Preclinical Study
16%
Drug Resistance
16%